Kontour (Xi'an) Medical Technology Co. Ltd.
Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sale of Class III implantable medical devices in China. The company offers products in the fields of neurosurgery cranial repair and fixation, cardiothoracic surgery sternum fixation, and maxillofacial repair. It also provides oral products, including implants, implant guides, titanium mesh, GBR … Read more
Kontour (Xi'an) Medical Technology Co. Ltd. (688314) - Total Assets
Latest total assets as of September 2025: CN¥790.93 Million CNY
Based on the latest financial reports, Kontour (Xi'an) Medical Technology Co. Ltd. (688314) holds total assets worth CN¥790.93 Million CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kontour (Xi'an) Medical Technology Co. Ltd. - Total Assets Trend (2017–2024)
This chart illustrates how Kontour (Xi'an) Medical Technology Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kontour (Xi'an) Medical Technology Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Kontour (Xi'an) Medical Technology Co. Ltd.'s total assets of CN¥790.93 Million consist of 56.0% current assets and 44.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 50.7% |
| Accounts Receivable | CN¥9.81 Million | 1.3% |
| Inventory | CN¥24.75 Million | 3.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥27.31 Million | 3.7% |
| Goodwill | CN¥6.02 Million | 0.8% |
Asset Composition Trend (2017–2024)
This chart illustrates how Kontour (Xi'an) Medical Technology Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kontour (Xi'an) Medical Technology Co. Ltd.'s current assets represent 56.0% of total assets in 2024, an increase from 53.4% in 2017.
- Cash Position: Cash and equivalents constituted 50.7% of total assets in 2024, up from 31.3% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 21.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 3.7% of total assets.
Kontour (Xi'an) Medical Technology Co. Ltd. Competitors by Total Assets
Key competitors of Kontour (Xi'an) Medical Technology Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Kontour (Xi'an) Medical Technology Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Kontour (Xi'an) Medical Technology Co. Ltd. generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Kontour (Xi'an) Medical Technology Co. Ltd. generates $ 11.83 in net profit.
Kontour (Xi'an) Medical Technology Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.86 | 4.77 | 3.79 |
| Quick Ratio | 4.51 | 4.48 | 2.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥335.31 Million | CN¥ 330.17 Million | CN¥ 105.49 Million |
Kontour (Xi'an) Medical Technology Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Kontour (Xi'an) Medical Technology Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.60 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 10.6% |
| Total Assets | CN¥747.22 Million |
| Market Capitalization | $161.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kontour (Xi'an) Medical Technology Co. Ltd.'s assets below their book value (0.22 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kontour (Xi'an) Medical Technology Co. Ltd.'s assets grew by 10.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kontour (Xi'an) Medical Technology Co. Ltd. (2017–2024)
The table below shows the annual total assets of Kontour (Xi'an) Medical Technology Co. Ltd. from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥747.22 Million | +10.57% |
| 2023-12-31 | CN¥675.79 Million | +5.90% |
| 2022-12-31 | CN¥638.14 Million | +11.29% |
| 2021-12-31 | CN¥573.38 Million | +96.70% |
| 2020-12-31 | CN¥291.51 Million | +27.68% |
| 2019-12-31 | CN¥228.32 Million | +46.82% |
| 2018-12-31 | CN¥155.51 Million | +20.96% |
| 2017-12-31 | CN¥128.56 Million | -- |